CDMO Custom Pharma Services expands operations

By Melissa Fassbender

- Last updated on GMT

Custom Pharma Services offers services ranging from clinical to commercial. (Image: iStock/KCHL)
Custom Pharma Services offers services ranging from clinical to commercial. (Image: iStock/KCHL)
The full-service contract development and manufacturing organization (CDMO) for investigational medicinal products has purchased a new building to expand its high containment manufacturing and development operations.

The new facility, dubbed the Custom Pharmaceutical Innovation Centre, is adjacent to Custom Pharma Services​'s existing packaging and warehousing operations on the Fairway Trading Estate in Brighton

According to the company, the expansion increases its capacity for clinical and product development of highly potent molecules. The new facility also supports the company’s commercial manufacturing capabilities with high containment capabilities in order to meet customer demand.

Nigel Richardson, CEO of Custom Pharma Services, explained work on the building will begin later this year. In the company’s press release, Richardson described the expansion as “a tremendous opportunity to consolidate our operations and concentrate on broadening our scope of services​.”

Related news

Show more

Related products

show more

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Product Brochure

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Addressing Challenges with Clinical In-Use Testing

Addressing Challenges with Clinical In-Use Testing

Content provided by Lonza | 12-Oct-2023 | White Paper

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Related suppliers

Follow us

Products

View more

Webinars